Benefits and side effects of semaglutide are among the most searched topics for people considering medicines such as Ozempic, Wegovy, and Rybelsus. Whether someone is using semaglutide for type 2 diabetes management, obesity treatment, chronic weight management, or improved blood sugar control, they often want to know what the real benefits are and which adverse effects they should watch for.

Semaglutide is a GLP-1 receptor agonist that works by reducing appetite, slowing stomach emptying, improving insulin sensitivity, and helping people feel fuller for longer. While many people experience weight loss benefits and better A1C reduction, others may notice gastrointestinal side effects, nausea, fatigue, acid reflux, sulfur burps, constipation, or more serious issues such as pancreatitis and gallbladder disease.

What Is Semaglutide and How Does It Work?

Semaglutide is a medicine used to treat type 2 diabetes and obesity. It belongs to a class of medicines called GLP-1 receptor agonists. These medicines copy the action of a natural hormone called glucagon-like peptide-1, which helps regulate appetite, insulin release, blood sugar levels, and stomach emptying.

You may know semaglutide through brand names such as Ozempic, Wegovy, and Rybelsus. Ozempic is mainly used for type 2 diabetes, Wegovy is approved for chronic weight management, and Rybelsus is the oral semaglutide tablet form.

Semaglutide works in several ways:

• It helps lower blood sugar after meals
• It reduces appetite and calorie intake
• It slows gastric emptying, which increases feelings of fullness
• It may improve insulin sensitivity
• It can support significant weight loss over time

Because semaglutide slows stomach emptying, many people feel full after eating smaller meals. This is one of the main reasons semaglutide weight loss results can be impressive when combined with healthy eating and regular exercise.

Recent research published in The New England Journal of Medicine by (Wilding et al., 2021) found that semaglutide produced substantial and sustained weight loss in adults with obesity when combined with lifestyle changes.

Key Benefits of Semaglutide for Weight Loss and Diabetes

One of the biggest semaglutide benefits is its ability to help people lose weight and improve blood sugar control at the same time. Many people with obesity and type 2 diabetes struggle with cravings, hunger, and insulin resistance. Semaglutide can help address all three.

Key semaglutide benefits include:

• Reduced appetite and fewer food cravings
• Improved blood sugar control
• Better A1C reduction
• Lower risk of cardiovascular disease
• Improved insulin sensitivity
• Potential improvement in fatty liver disease
• Reduced binge eating behaviour
• Better blood pressure control
• Lower risk of heart attack and stroke

Some newer research suggests semaglutide may offer benefits beyond weight loss. Studies show it may improve symptoms of sleep apnoea, polycystic ovary syndrome, and fatty liver disease. Researchers are also exploring whether semaglutide may reduce cravings for alcohol, smoking, and highly processed foods.

The SELECT trial (Lincoff et al., 2023) found that semaglutide reduced the risk of major cardiovascular events in adults with obesity and cardiovascular disease, even in those without diabetes .

Common Side Effects of Semaglutide

Although semaglutide has many benefits, it can also cause side effects. The most common semaglutide side effects are gastrointestinal.

Common side effects include:

• Nausea and vomiting
• Diarrhoea and constipation
• Bloating
• Acid reflux
• Sulfur burps
• Fatigue and weakness
• Dizziness
• Reduced appetite
• Stomach pain
• Headache

These symptoms are often worse during the first few weeks or after a dose increase. Many people notice that semaglutide side effects improve over time as the body adjusts.

I often recommend eating smaller meals, avoiding greasy foods, limiting alcohol, and drinking enough water to reduce gastrointestinal side effects. High-fat meals can make nausea, bloating, and reflux worse.

People also ask about semaglutide and coffee, semaglutide and alcohol, and semaglutide and spicy foods. In some people, coffee may worsen nausea or acid reflux, while alcohol can increase the risk of dehydration and low blood sugar.

A review in JAMA by (Rubino et al., 2022) found that nausea, diarrhoea, vomiting, and constipation were among the most common adverse effects reported with semaglutide use .

Semaglutide Side Effects Week by Week

Many people search for semaglutide side effects first week because symptoms can change over time.

During week 1 to 2, people often report:

• Mild nausea
• Reduced appetite
• Feeling full quickly
• Fatigue
• Mild constipation

By weeks 3 to 4, symptoms may include:

• Sulfur burps
• Acid reflux
• Diarrhoea
• Food aversion
• Bloating

After dose increases, some people experience worsening nausea, tiredness, dizziness, or constipation. Symptoms usually settle after a few days.

If someone has severe vomiting, dehydration, chest pain, intense abdominal pain, or signs of pancreatitis, they should contact a healthcare professional urgently.

Rare but Serious Side Effects of Semaglutide

Some semaglutide adverse effects are uncommon but can be serious.

These include:

• Pancreatitis
• Gallstones and gallbladder disease
• Kidney injury
• Severe dehydration
• Thyroid cancer warning
• Bowel obstruction
• Diabetic retinopathy worsening
• Blurred vision
• Rapid heartbeat
• Allergic reactions

Semaglutide carries a warning about thyroid C-cell tumours based on animal studies. People with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 should usually avoid semaglutide.

There is also growing interest in semaglutide and eye damage, especially in people with diabetic retinopathy. Rapid improvements in blood sugar may temporarily worsen diabetic eye disease in some patients.

Research from Diabetes Care (Marso et al., 2017) reported that semaglutide may worsen diabetic retinopathy in certain high-risk individuals, particularly those with pre-existing eye disease and rapid A1C reduction .

Can Semaglutide Cause Hair Loss, Loose Skin, and Ozempic Face?

Many people are surprised when they notice physical changes after rapid weight loss.

Hair loss, loose skin, and Ozempic face are often linked to weight loss itself rather than semaglutide directly. When someone loses weight quickly, they may lose fat from the face, buttocks, breasts, and other areas.

This can lead to:

• A more hollow facial appearance
• Loose skin around the stomach or arms
• Thinning hair
• Muscle loss
• Sagging skin

Eating enough protein, strength training, and staying hydrated may help reduce some of these effects.

Foods to Eat and Avoid While Taking Semaglutide

Food choices can make a huge difference to semaglutide side effects.

Foods that may worsen symptoms include:

• Fried foods
• Fatty meals
• Spicy foods
• Sugary drinks
• Alcohol
• Very large meals

Foods that may help include:

• Lean protein
• High-fibre foods
• Oats
• Bananas
• Soup
• Crackers
• Greek yoghurt
• Plenty of water

Many people do better with small meals eaten slowly. Eating too quickly or eating large portions can worsen nausea and bloating.

Can You Drink Alcohol or Coffee While Taking Semaglutide?

Semaglutide and alcohol can be a difficult combination for some people. Alcohol may increase nausea, dehydration, dizziness, and low blood sugar.

Coffee may also worsen reflux, sulfur burps, and stomach discomfort in sensitive people.

If someone wants to drink alcohol or coffee while taking semaglutide, it is usually best to:

• Start with a small amount
• Avoid drinking on an empty stomach
• Drink more water
• Monitor symptoms carefully

FAQ About Benefits and Side Effects of Semaglutide

Does Semaglutide Make You Tired?

Yes. Fatigue is a common side effect, especially during the first few weeks or after dose increases.

Why Am I Not Losing Weight on Semaglutide?

Some people may not lose weight because of low protein intake, poor sleep, high calorie drinks, stress, or insufficient dose adjustments.

What Happens If You Stop Semaglutide?

Stopping semaglutide may lead to rebound hunger, increased cravings, and weight regain.

Can Semaglutide Cause Anxiety or Depression?

Some people report mood changes, anxiety, irritability, or low mood, although more research is needed.

Can Semaglutide Affect Periods or Fertility?

Weight loss and hormone changes may affect menstrual cycles and fertility, especially in women with PCOS.

References

• Wilding, J.P.H., Batterham, R.L., Calanna, S., Davies, M., Van Gaal, L.F., Lingvay, I., McGowan, B.M., Rosenstock, J., Tran, M.T.D., Wadden, T.A., Wharton, S., Yokote, K., Zeuthen, N. and Kushner, R.F. (2021) ‘Once-Weekly Semaglutide in Adults with Overweight or Obesity’, New England Journal of Medicine, 384(11), pp. 989–1002. Available at: Once-Weekly Semaglutide in Adults with Overweight or Obesity .
• Lincoff, A.M., Brown-Frandsen, K., Colhoun, H.M., Deanfield, J., Emerson, S.S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G.K., Kahn, S.E., Kushner, R.F., Lingvay, I., Oral, T.K., Michelsen, M.M., Plutzky, J., Tornøe, C.W. and Ryan, D.H. (2023) ‘Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes’, New England Journal of Medicine, 389(24), pp. 2221–2232. Available at: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes .
• Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F.L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M.A., Rudofsky, G., Tadayon, S., Wadden, T.A. and Dicker, D. (2021) ‘Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial’, JAMA, 325(14), pp. 1414–1425. Available at: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity .
• Marso, S.P., Bain, S.C., Consoli, A., Eliaschewitz, F.G., Jódar, E., Leiter, L.A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M.L., Woo, V., Hansen, O., Holst, A.G., Pettersson, J. and Vilsbøll, T. (2016) ‘Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes’, New England Journal of Medicine, 375(19), pp. 1834–1844. DOI: 10.1056/NEJMoa1607141.
• Marso, S.P., Daniels, G.H., Brown-Frandsen, K., Kristensen, P., Mann, J.F.E., Nauck, M.A., Nissen, S.E., Pocock, S., Poulter, N.R., Ravn, L.S., Steinberg, W.M., Stockner, M., Zinman, B., Bergenstal, R.M. and Moses, A.C. (2017) ‘Liraglutide and Semaglutide: Diabetic Retinopathy and Cardiovascular Outcomes’, Diabetes Care, 41(2), pp. e17–e19. DOI: 10.2337/dc17-1763.